A systematic review on quality of life (QoL) of patients with peritoneal metastasis (PM) who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Zhenyue LiLouis Choon Kit WongRehena SultanaHui Jun LimJoey Wee-Shan TanQiu Xuan TanJolene Si Min WongClaramae Shulyn ChiaChin-Ann Johnny OngPublished in: Pleura and peritoneum (2022)
PIPAC is a well-tolerated option for most GC and EOC patients with irresectable PM. Future trials are warranted to confirm the findings.